Lowtan Plus Tablets (Olmesartan Medoxomil, Hydrochlorothiazide)

Adult dose

Before administering this medication, it is recommended to adjust the dosage of Olmesartan Medoxomil or Hydrochlorothiazide alone; if blood pressure is not adequately controlled, administer 1 tablet once daily regardless of meals. The dosage should be adjusted every 2 to 4 weeks based on the patient's blood pressure response. Elderly patients should start at the lowest dose, and careful consideration should be given to kidney function, cardiac function, comorbid conditions, and concomitant medications when adjusting the dose. Patients with renal failure (creatinine clearance)

Child dose

Safety and efficacy in children have not been established.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients in this medication or with certain kidney or liver diseases should not take it. Patients with decreased blood volume, weak kidney function, or liver disease should consult with their doctor before use for careful administration. Due to its blood pressure-lowering effects, dizziness or hypotension may occur in the early stages of treatment, requiring caution. Due to Hydrochlorothiazide, electrolyte imbalances, particularly changes in potassium and sodium levels, may occur, necessitating regular testing. If any allergic reactions such as skin rash, itching, facial swelling, or difficulty breathing occur during treatment, medical personnel should be notified immediately. This medication may interact with other antihypertensives, potassium supplements, or diuretics, so it is essential to inform the healthcare provider of any other medications being taken. Elderly patients, children, and those with specific medical conditions may require dosage adjustments, and safety and efficacy in pediatric patients have not been established. In cases of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, necessitating immediate medical treatment. The Hydrochlorothiazide component may react sensitively to sunlight, so long-term exposure to ultraviolet light should be avoided, and caution should be exercised if any skin abnormalities occur. During treatment, caution must be taken when undertaking dangerous tasks such as driving or operating machinery, as dizziness or drowsiness may occur. If pregnant or breastfeeding, consider avoiding this medication and consulting a specialist, especially since it may affect the baby during breastfeeding. If any unusual symptoms occur during treatment, consult medical personnel immediately, and regular blood tests and kidney function tests are essential.

Serious side effects

Hives, severe swelling (facial edema, angioedema), chest tightness, difficulty breathing, anaphylactic reaction, paleness, severe rash with high fever, blisters, peeling skin, pain in mouth/eyes mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory problems accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe

Mild side effects

Nausea, metabolic disorders (hyperuricemia, hyperlipidemia, hyperglycemia), dizziness, upper respiratory infection, headache, urinary tract infection, chest pain, back pain, peripheral edema, abdominal pain, dyspepsia, gastroenteritis, diarrhea, increased AST, increased GGT, increased ALT, increased creatine phosphokinase, arthritis, arthralgia, myalgia, cough, rash, hematuria, weakness, vomiting, hair loss, itching, hives, elevated blood pressure, palpitations, fatigue, drowsiness,

This medication should be stored in a tightly closed container to protect it from air and moisture. A storage temperature of room temperature between 1 and 25 degrees Celsius is recommended.

Appearance

Yellowish red round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle